Pet Medications Marketing & Retail Trends: United States Report

Report Overview

This report discusses US pet medication marketing and retail trends. Data is presented in nominal US dollars.
This report provides a general overview of the retail market for medications for domesticated dogs and cats, with a focus on products purchased directly by consumers. These include both prescription and over-the-counter (also called OTC or retail) medications. The primary focus of this report is on the core types of antiparasitics/ parasiticides – heartworm preventatives, flea/tick preventatives, and heartworm/flea combo products, and other dewormers (some of which also target other external parasites such as mosquitoes, flies, ear mites, lice, and sarcoptic mange, and/or other types of internal parasites such as hookworms, roundworms, whipworms, and tapeworms). “Flea/tick” can refer to products that treat only fleas and ticks, but can also refer to combination products that additionally treat worms, mites, etc., except heartworms. Also covered are market-shaping developments in other areas, including anxiety, pain management, cancer, cognitive dysfunction, and obesity/diabetes.
Animal health products for production animals and horses are excluded from this market analysis, as are nutritional supplements for companion animals, which are covered in Packaged Facts’ March 2026 report Pet Supplements in the US.
A full outline of report items by page is available in the Table of Contents.

Related NAICS Codes

Table of Contents

• Types of Marketers Competing in the Pet Medications Market
• Innovation Encouragement
• Impact of Generics
• Pet Tech/AI

• Retail Shares of Pet Medications
• Influence of the Internet
• Retailers & Pet Meds
• Veterinary Influence

• Scope
• Sources
• Industry Codes
• Resources

• Figure 1 | Retail Shares of Pet Medication Sales by Non-Veterinary Channel, 2025 (%)
• Table 1 | NAICS & SIC Codes Related to Pet Medications